Jya-wei Cheng

Hsinchu, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Sequence Permutation Generated Lysine and Tryptophan-Rich Antimicrobial Peptides with Enhanced Therapeutic Index.

Sequence Permutation Generated Lysine and Tryptophan-Rich Antimicrobial Peptides with Enhanced Therapeutic Index.

Journal: Antibiotics (Basel, Switzerland)

Published: September 30, 2025

High Level Expression and Purification of Cecropin-like Antimicrobial Peptides in Escherichia coli.

High Level Expression and Purification of Cecropin-like Antimicrobial Peptides in Escherichia coli.

Journal: Biomedicines

Published: May 18, 2022

Strategy to Enhance Anticancer Activity and Induced Immunogenic Cell Death of Antimicrobial Peptides by Using Non-Nature Amino Acid Substitutions.

Strategy to Enhance Anticancer Activity and Induced Immunogenic Cell Death of Antimicrobial Peptides by Using Non-Nature Amino Acid Substitutions.

Journal: Biomedicines

Published: April 07, 2022

Boosting Synergistic Effects of Short Antimicrobial Peptides With Conventional Antibiotics Against Resistant Bacteria.

Boosting Synergistic Effects of Short Antimicrobial Peptides With Conventional Antibiotics Against Resistant Bacteria.

Journal: Frontiers in microbiology

Published: July 26, 2021

Antimicrobial Peptides with Enhanced Salt Resistance and Antiendotoxin Properties.

Antimicrobial Peptides with Enhanced Salt Resistance and Antiendotoxin Properties.

Journal: International journal of molecular sciences

Published: August 13, 2020

Antimicrobial Peptides Display Strong Synergy with Vancomycin Against Vancomycin-Resistant E. faecium, S. aureus, and Wild-Type E. coli.

Antimicrobial Peptides Display Strong Synergy with Vancomycin Against Vancomycin-Resistant E. faecium, S. aureus, and Wild-Type E. coli.

Journal: International journal of molecular sciences

Published: May 30, 2020

The Interactions between the Antimicrobial Peptide P-113 and Living Candida albicans Cells Shed Light on Mechanisms of Antifungal Activity and Resistance.

The Interactions between the Antimicrobial Peptide P-113 and Living Candida albicans Cells Shed Light on Mechanisms of Antifungal Activity and Resistance.

Journal: International journal of molecular sciences

Published: March 22, 2020

A novel CXCL8 analog is effective in inhibiting the growth via cell cycle arrest and attenuating invasion of Lewis lung carcinoma.

A novel CXCL8 analog is effective in inhibiting the growth via cell cycle arrest and attenuating invasion of Lewis lung carcinoma.

Journal: OncoTargets and therapy

Published: May 17, 2019

IL-8 analogue CXCL8 (3-72) K11R/G31P, modulates LPS-induced inflammation via AKT1-NF-kβ and ERK1/2-AP-1 pathways in THP-1 monocytes.

IL-8 analogue CXCL8 (3-72) K11R/G31P, modulates LPS-induced inflammation via AKT1-NF-kβ and ERK1/2-AP-1 pathways in THP-1 monocytes.

Journal: Human immunology

Published: July 20, 2018

A novel CXCL8-IP10 hybrid protein is effective in blocking pulmonary pathology in a mouse model of Klebsiella pneumoniae infection.

A novel CXCL8-IP10 hybrid protein is effective in blocking pulmonary pathology in a mouse model of Klebsiella pneumoniae infection.

Journal: International immunopharmacology

Published: May 08, 2018

IL-8 antagonist, CXCL8(3-72)K11R/G31P coupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitis.

IL-8 antagonist, CXCL8(3-72)K11R/G31P coupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 17, 2018

High Level Expression and Purification of the Clinically Active Antimicrobial Peptide P-113 in Escherichia coli.

High Level Expression and Purification of the Clinically Active Antimicrobial Peptide P-113 in Escherichia coli.

Journal: Molecules (Basel, Switzerland)

Published: January 24, 2018

Showing 1-12 of 27

Last Updated: 09/26/2026